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Chronic Muscle Pain
Mike Bozzi
JFMA PGY-2
Learning Objectives
● How to approach the patient with chronic muscle pain
● How a complete history and physical can prevent extraneous testing and 
unnecessary or premature referrals
● Treatment strategies 
Case
JM, 57 year old female
Reason for visit: pain everywhere
Differential Diagnosis
Rheumatologic/Inflammatory 
RA/lupus/Sjogren’s 
Polymyalgia rheumatica
Spondyloarthritis
Osteoarthritis
Fibromyalgia
Infectious
Virus (HIV, Hep B/C, influenza, chikungunya…)
Lyme disease
Pyomyositis 
Neurologic
Chronic neuropathy
Opioid induced hyperalgesia
Muscle Disease
Muscle strain/overuse injuries
Rhabdomyolysis
Metabolic
Hypothyroidism
Cushing’s syndrome 
Hypercalcemia/hyperparathyroidism
Hyperkalemia
Drug-induced myopathies
Statin 
Glucocorticoid 
Hydroxychloroquine 
Alcohol
Decision Points
Where is the pain? - local vs diffuse, joints vs muscles
Timeline - acute vs chronic, constant vs intermittent
Is strength affected? - intact vs decreased
What labs should I get? - Inflammatory vs non-inflammatory
What else is going on? - comorbid conditions, exacerbating factors
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JM
JM is a 57 year old female presents with diffuse pain for the past 2 months. She 
feels the pain began in her back and shoulders but quickly spread to the rest of her 
body. When asked if she can point to any specific spots now she gestures generally 
and says “all over.” She describes the pain as a constant dull ache with increased 
tenderness to light palpation in various locations. There is no clear association with 
time of day or activity, though she does feel stiff for 15-30 minutes in the morning. 
She does not regularly exercise but says her activity level has been worse than 
usual recently because of the pain. She has been unable to get a full night of sleep 
in several months and is constantly fatigued, which has taken a significant toll on 
her mood, which she describes today as “awful.” She asks you to “please make the 
pain go away.”
Additional information
PMH: hypertension, hypercholesterolemia, obesity, bilateral knee OA, depression
PSH: lap chole at age 44, C-section x2
Medications: HCTZ-lisinopril, atorvastatin, tylenol, sertraline
Allergies: none
SH: works in billing dept for a real estate company, married with two children, lives 
in a row home in Northeast Philly, never smoker, occasional alcohol, no drugs. 
FH: hypertension and heart disease in her father, diabetes in her mother and sister
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The Importance of a Complete Physical Exam
Skin - careful examination for rashes and skin changes, particularly 
overlying joints, on the hands, and on the face
Joints - assess for effusions, mobility, tenderness
Muscles - assess for tenderness in multiple areas, strength (subjective 
vs objective, proximal vs distal vs diffuse)
Which muscles to test?
Deltoids - shoulder shrug
Neck flexors - push against forehead
Wrist extensors - pull hand back
Grip strength - squeeze fingers
Thigh flexion - lift leg off table
Ankle flexion/extension - dorsi- and plantarflexion of foot
Physical Exam
General: tired appearing, no acute distress, speaking in a soft voice
HEENT/Neck: EOMI, PERRL, moist mucous membranes, no LAD, no thyromegaly, neck 
circumference within normal limits
Chest: lungs clear bilaterally, no chest wall tenderness
Cardiac: RRR, no murmurs
Abdomen: mild diffuse tenderness to palpation, no rebound/guarding, normal bowel sounds
MSK: 5/5 strength throughout with giveaway weakness on shoulder shrug and hip flexion; 
tenderness to palpation in the bilateral deltoids, biceps, quads, calves, upper back, lower 
back without bony deformity; moderate bilateral knee tenderness to palpation without 
significant effusion; no hand deformities, no synovitis, ROM of all joints intact
Neuro: sensation intact throughout
Skin: no rashes, no jaundice, no pallor
Psych: depressed affect, normal thought content, no SI
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Okay so what should we do?
Labs
● CBC?
● CMP?
● TSH?
● ESR/CRP?
● CK?
● RF? ANA?
● Lyme? 
Medications
● Start? 
● Stop?
Imaging
● Ultrasound? X-rays?
Referrals 
● Rheum?
Okay so what should we do?
Labs
● CBC - Yes
● CMP - Yes
● TSH - Yes*
● ESR/CRP - Yes*
● CK - Yes*
● RF? ANA? No 
● Lyme? Please, no
Follow up: return to clinic in two weeks
Medications
● Start - trial NSAIDs (eg. naproxen)
● Stop - statin
Imaging
● No thank you
Referrals 
● Not yet
Two weeks later
Mrs. M returns to the clinic two weeks later and notes that her symptoms are 
unchanged since her last visit. She stopped her statin as instructed. The naproxen 
you gave her did not seem to help her pain at all; sleep and mood have continued 
to be particularly poor. Her exam is unchanged.
Lab results:
CBC: within normal limits
CMP: within normal limits
TSH: within normal limits
CK: within normal limits
ESR: 33 - (normal is 0-30 for women age >50; alternative is [age+10]/2)
Now what?
Inflammatory or Non-inflammatory?
OK so the ESR is mildly elevated. Reminder that this is a very non-specific test but 
also not entirely sensitive for conditions like PMR or early RA. 
So how else can we distinguish inflammatory from non-inflammatory conditions?
Let’s try something.
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also not entirely sensitive for conditions like PMR or early RA. 
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Prednisone 5 mg BID for a week…
Inflammatory or Non-inflammatory?
OK so the ESR is mildly elevated. Reminder that this is a very non-specific test but 
also not entirely sensitive for conditions like PMR or early RA. 
So how else can we distinguish inflammatory from non-inflammatory conditions?
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Mrs. M comes back another two weeks later and says nope. Nada. No different.
Fibromyalgia
Fibromyalgia
Fibromyalgia is a chronic neurologic syndrome characterized by pain all 
over the body and tenderness or increased sensitivity to touch, along with 
other cognitive symptoms including fatigue, memory problems, difficulty 
concentrating, and sleep disturbances. It is not an inflammatory or 
autoimmune condition, at least as far as has been established with current 
research.
Epidemiology of Fibromyalgia
Prevalence: the CDC estimates that approximately 2% of the adult population in the 
US have FM, or about 4 million people, though some estimates are as high as 5%
Age: presentation can occur at any age, with the majority experiencing onset 
between the age of 20 and 50
Gender: women are estimated to be at 2 to 9 times greater risk for FM
Genomic studies have found a handful of genes associated with an increased risk 
of developing the condition and a relative risk up to 13-fold among first degree 
relatives of patients with FM, indicating a possible genetic predisposition.
Pathophysiology of Fibromyalgia
The exact pathophysiology of fibromyalgia has yet to be elucidated.
While there is no unifying clinical history, FM diagnoses are almost always 
preceded by a triggering factor or event such as arthritis, low back pain, infection, 
physical or emotional trauma.
Characteristic chronic widespread pain thought to result from sustained release of 
proinflammatory cytokines and chemokines in the CNS, resulting in 
neuroinflammation and altered connectivity between brain regions.
Chronic Widespread Pain and Central Sensitization
Neurologic Differences
Compared to healthy controls, 
patients with fibromyalgia have 
increased connectivity with the 
cerebellum and decreased 
connectivity with the prefrontal 
cortex.
Gray matter density in these regions 
associated quantitatively with 
depression symptoms and the 
number of fibers correlated with 
severity of hyperalgesia.
Diagnostic Criteria
Three criteria must be met for the diagnosis of fibromyalgia:
1) Widespread pain and significant symptoms severity, as assessed by 
the Widespread Pain Index (WPI) and Symptoms Severity Score (SS) 
2) Symptoms present at similar level for at least three months
3) No alternative diagnosis that would explain the symptoms
https://www.researchgate.net/figure/Diagnostic-and-Severity-Criteria-for-Fibromyalgia-Widespread-Pain-Index-WPI-Adapted_fig2_331801810
https://www.researchgate.net/figure/Diagnostic-and-Severity-Criteria-for-Fibromyalgia-Widespread-Pain-Index-WPI-Adapted_fig2_331801810
Symptom Severity Scale
Operates on a scale from 0-12 by summing the answers to these questions:
Level of symptom severity over the past week, on a scale from 0 to 3:
● Fatigue 
● Waking unrefreshed
● Cognitive Symptoms
Presence of these symptoms in the past six months (N=0, Y=1):
● Depression
● Pain or cramps in lower abdomen
● Headache
Meeting the Criteria
WPI ≥ 7 and SS ≥ 5
OR
WPI ≥ 3 and SS ≥9
In combination, these work within a spectrum of pain and cognitive/mood 
symptoms to allow for significant leeway in diagnosis.
Diagnostic Criteria
Three criteria must be met for the diagnosis of fibromyalgia:
1) Widespread pain and significant symptoms severity, as assessed by 
the Widespread Pain Index (WPI) and Symptoms Severity Score (SS) 
2) Symptoms present at similar level for at least three months
3) No alternative diagnosis that would explain the pain
Alternative and Contributing Diagnoses
Connective Tissue Diseases - high prevalence of FM in patients with RA and other 
CTDs; treat both modalities at once
Polymyalgia rheumatica - look for signs of inflammation, treat with steroids when 
appropriate, wean off as able. 
Myopathies - is that statin causing problems?
Sleep apnea - if you have a patient saying they’re always fatigued, waking up 
unrefreshed, having difficulty concentrating you would probably get a sleep study
Depression - comorbid and contributing, mental and physical symptoms can play 
off of each other and should both be addressed
Comorbidities
Sleep disturbances and chronic fatigue (90%)
Degenerative Joint Disease (88%)
Depression (75%)
Irritable bowel syndrome (70%)
Migraine/chronic headache (62%)
Anxiety (57%)
PTSD (56%)
Brain fog (50%)
Obesity (50%)
Interstitial cystitis (39%)
Back to our patient
JM has now been having chronic diffuse muscle pain for the past three months. 
Based on the widespread pain index and the symptom severity scale, she meets 
criteria for fibromyalgia and no alternative diagnosis has been established. 
So now what do we do?
Initial Treatment of Fibromyalgia
1. Education, reassurance, validation, and expectation setting
- put a name to their condition
- acknowledge the realness of their symptoms and 
- set realistic goals and expectations for their long term outcomes
1. Physical activity
- low impact aerobic exercise (swimming, walking, biking) 
- tai chi
1. Physical therapy 
- find a therapist that specializes in chronic pain conditions
1. Cognitive behavioral therapy 
- work on mood symptoms, coping strategies, and evaluate for past trauma
1. Sleep
- assess and improve sleep hygiene
- sleep study to rule out other common causes of sleep disturbance
One Month Later
Mrs. M returns to the clinic and notes her pain symptoms have improved “a little.” 
She had her sleep study done, which did not reveal any abnormalities, and has 
been working on putting her phone away before bed. She has been using an online 
tai chi class and says she finds the classes to be relaxing. She has been to a few 
therapy sessions so far but still feels depressed. She is still markedly fatigued. She 
asks if there are any medications that can help.
Medication Treatment of Fibromyalgia
Initial therapy should be selected based on the prominence of patients’ symptoms 
and contraindications to their common side effects:
Amitriptyline 10 mg at bedtime
● Why it’s good: modest benefit in treating pain and sleep
● Why it’s bad: not a good medication for older patients or those prone to 
anticholinergic side effects
Duloxetine 60 mg with breakfast
● Why it’s good: activating, helps patients with severe fatigue/depression
● Why it’s bad: activating, exacerbates anxiety symptoms, doesn’t help sleep
Gabapentin 100 mg at bedtime
● Why it’s good: can add on for pain and sleep symptoms
● Why it’s bad: no impact on depressive/fatigue symptoms, can be sedating
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Medication Personalization for Fibromyalgia 
Pain
Sleep 
Disturbance
Fatigue
Depression
Gabapentin
Pregabalin
Duloxetine
Amitriptyline 
SSRI
Cyclobenzaprine
So what should we 
prescribe Mrs. M?
Long Term Follow Up
Patients often benefit from regular follow up with a consistent provider to monitor 
their symptoms, titrate dosing, and observe for side effects.
Vigilance is necessary. It is tempting to forego in depth physical exams on these 
patients but it is important to track their symptom severity as well as to monitor for 
the development of new signs of pathology. Continue to look for rashes, synovitis, 
and other joint pathologies. 
Inflammatory Condition Fibromyalgia
Inflammatory ConditionFibromyalgia
Prognosis
The numbers needed to treat with these medications are relatively high and the 
successes are often measured as patients with a 30% reduction in symptoms.
Most patients will continue to have chronic pain and fatigue to a significant degree 
with a large percentage being chronically disabled.
Worse prognoses are correlated with female gender, low socioeconomic status, 
unemployment, depression, catastrophizing, and a history of abuse. 
There is no clear impact on mortality, though patients with comorbidities are at a 
markedly increased risk for suicide.
Key Points
● Fibromyalgia pain is real pain
● A detailed history and physical can prevent unnecessary testing
● Comorbidities are common and debilitating
● Treatment should be tailored to the individual patient’s needs and should not 
forget the underlying conditions
● Don’t dismiss new pain and symptoms
Questions?
Special thanks to my 
friendly neighborhood 
PCP and rheumatologist, 
Dr. Catharine Arnold.
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